PainChek Limited (ASX:PCK) Releases Half Year Results
PainChek Limited (ASX:PCK) reports a 27% revenue increase in its half-year results, highlighting growth and expansion into the US market.
PainChek Limited (ASX:PCK) reports a 27% revenue increase in its half-year results, highlighting growth and expansion into the US market.
Vection Technologies (ASX:VR1) reports a 15% revenue increase in 1H25 and significant EBITDA improvement, accelerating towards profitability.
The Hydration Pharmaceuticals Company Limited (ASX:HPC) reports a 25.5% revenue decline in FY2024, asset divestiture, and a strategic focus on US growth.
TasFoods Ltd (ASX:TFL) reports FY2024 results, showing improved EBITDA, cost reductions, and expansion in Pet Treats and Pyengana Dairy segments.
Ariadne Australia Limited (ASX:ARA) reports a 62.5% revenue increase and declares a fully franked interim dividend.
Epsilon Healthcare (ASX:EPN) reports a 43% revenue increase and a 92% reduction in net loss for 2023, alongside entering Voluntary Administration.
Life360 (ASX:360) reports record Q4 and FY 2024 results with 33% revenue growth and 79.6 million active users.
Sayona Mining Limited (ASX:SYA) reports a 3% revenue increase and significantly reduced losses in its half-year financial results, alongside leadership changes and a strategic merger.
Vysarn Limited (ASX:VYS) reports a 5% revenue increase and strong operational cashflow for 1HFY25, surpassing guidance and advancing growth through strategic acquisitions.
WhiteHawk Limited (ASX:WHK) reports a 15.6% revenue increase for 2024 and renews a $2.4M contract, demonstrating financial improvement and growth.